Copyright Reports & Markets. All rights reserved.

Global NGS-based RNA-sequencing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Sequencing by Synthesis
    • 1.4.3 Ion Semiconductor Sequencing
    • 1.4.4 Single-molecule Real-time Sequencing
    • 1.4.5 Nanopore Sequencing
  • 1.5 Market by Application
    • 1.5.1 Global NGS-based RNA-sequencing Market Share by Application: 2020 VS 2026
    • 1.5.2 Research & Academia
    • 1.5.3 Hospitals & Clinics
    • 1.5.4 Pharmaceutical & Biotechnology Companies
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): NGS-based RNA-sequencing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the NGS-based RNA-sequencing Industry
      • 1.6.1.1 NGS-based RNA-sequencing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and NGS-based RNA-sequencing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for NGS-based RNA-sequencing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 NGS-based RNA-sequencing Market Perspective (2015-2026)
  • 2.2 NGS-based RNA-sequencing Growth Trends by Regions
    • 2.2.1 NGS-based RNA-sequencing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 NGS-based RNA-sequencing Historic Market Share by Regions (2015-2020)
    • 2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 NGS-based RNA-sequencing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key NGS-based RNA-sequencing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top NGS-based RNA-sequencing Players by Market Size
    • 3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2015-2020)
    • 3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global NGS-based RNA-sequencing Market Concentration Ratio
    • 3.2.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2019
  • 3.3 NGS-based RNA-sequencing Key Players Head office and Area Served
  • 3.4 Key Players NGS-based RNA-sequencing Product Solution and Service
  • 3.5 Date of Enter into NGS-based RNA-sequencing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2015-2020)
  • 4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2021-2026)

5 NGS-based RNA-sequencing Breakdown Data by Application (2015-2026)

  • 5.1 Global NGS-based RNA-sequencing Market Size by Application (2015-2020)
  • 5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America NGS-based RNA-sequencing Market Size (2015-2020)
  • 6.2 NGS-based RNA-sequencing Key Players in North America (2019-2020)
  • 6.3 North America NGS-based RNA-sequencing Market Size by Type (2015-2020)
  • 6.4 North America NGS-based RNA-sequencing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe NGS-based RNA-sequencing Market Size (2015-2020)
  • 7.2 NGS-based RNA-sequencing Key Players in Europe (2019-2020)
  • 7.3 Europe NGS-based RNA-sequencing Market Size by Type (2015-2020)
  • 7.4 Europe NGS-based RNA-sequencing Market Size by Application (2015-2020)

8 China

  • 8.1 China NGS-based RNA-sequencing Market Size (2015-2020)
  • 8.2 NGS-based RNA-sequencing Key Players in China (2019-2020)
  • 8.3 China NGS-based RNA-sequencing Market Size by Type (2015-2020)
  • 8.4 China NGS-based RNA-sequencing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan NGS-based RNA-sequencing Market Size (2015-2020)
  • 9.2 NGS-based RNA-sequencing Key Players in Japan (2019-2020)
  • 9.3 Japan NGS-based RNA-sequencing Market Size by Type (2015-2020)
  • 9.4 Japan NGS-based RNA-sequencing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia NGS-based RNA-sequencing Market Size (2015-2020)
  • 10.2 NGS-based RNA-sequencing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia NGS-based RNA-sequencing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia NGS-based RNA-sequencing Market Size by Application (2015-2020)

11 India

  • 11.1 India NGS-based RNA-sequencing Market Size (2015-2020)
  • 11.2 NGS-based RNA-sequencing Key Players in India (2019-2020)
  • 11.3 India NGS-based RNA-sequencing Market Size by Type (2015-2020)
  • 11.4 India NGS-based RNA-sequencing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America NGS-based RNA-sequencing Market Size (2015-2020)
  • 12.2 NGS-based RNA-sequencing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America NGS-based RNA-sequencing Market Size by Type (2015-2020)
  • 12.4 Central & South America NGS-based RNA-sequencing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Illumina
    • 13.1.1 Illumina Company Details
    • 13.1.2 Illumina Business Overview and Its Total Revenue
    • 13.1.3 Illumina NGS-based RNA-sequencing Introduction
    • 13.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2015-2020))
    • 13.1.5 Illumina Recent Development
  • 13.2 Thermo Fischer Scientific
    • 13.2.1 Thermo Fischer Scientific Company Details
    • 13.2.2 Thermo Fischer Scientific Business Overview and Its Total Revenue
    • 13.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
    • 13.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.2.5 Thermo Fischer Scientific Recent Development
  • 13.3 Oxford Nanopore
    • 13.3.1 Oxford Nanopore Company Details
    • 13.3.2 Oxford Nanopore Business Overview and Its Total Revenue
    • 13.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
    • 13.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.3.5 Oxford Nanopore Recent Development
  • 13.4 Agilent Technologies
    • 13.4.1 Agilent Technologies Company Details
    • 13.4.2 Agilent Technologies Business Overview and Its Total Revenue
    • 13.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
    • 13.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.4.5 Agilent Technologies Recent Development
  • 13.5 BGI
    • 13.5.1 BGI Company Details
    • 13.5.2 BGI Business Overview and Its Total Revenue
    • 13.5.3 BGI NGS-based RNA-sequencing Introduction
    • 13.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.5.5 BGI Recent Development
  • 13.6 PerkinElmer
    • 13.6.1 PerkinElmer Company Details
    • 13.6.2 PerkinElmer Business Overview and Its Total Revenue
    • 13.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
    • 13.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.6.5 PerkinElmer Recent Development
  • 13.7 QIAGEN
    • 13.7.1 QIAGEN Company Details
    • 13.7.2 QIAGEN Business Overview and Its Total Revenue
    • 13.7.3 QIAGEN NGS-based RNA-sequencing Introduction
    • 13.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.7.5 QIAGEN Recent Development
  • 13.8 Eurofins Scientific
    • 13.8.1 Eurofins Scientific Company Details
    • 13.8.2 Eurofins Scientific Business Overview and Its Total Revenue
    • 13.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
    • 13.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.8.5 Eurofins Scientific Recent Development
  • 13.9 Roche
    • 13.9.1 Roche Company Details
    • 13.9.2 Roche Business Overview and Its Total Revenue
    • 13.9.3 Roche NGS-based RNA-sequencing Introduction
    • 13.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.9.5 Roche Recent Development
  • 13.10 Takara Bio
    • 13.10.1 Takara Bio Company Details
    • 13.10.2 Takara Bio Business Overview and Its Total Revenue
    • 13.10.3 Takara Bio NGS-based RNA-sequencing Introduction
    • 13.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 13.10.5 Takara Bio Recent Development
  • 13.11 GENEWIZ
    • 10.11.1 GENEWIZ Company Details
    • 10.11.2 GENEWIZ Business Overview and Its Total Revenue
    • 10.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
    • 10.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 10.11.5 GENEWIZ Recent Development
  • 13.12 Hamilton
    • 10.12.1 Hamilton Company Details
    • 10.12.2 Hamilton Business Overview and Its Total Revenue
    • 10.12.3 Hamilton NGS-based RNA-sequencing Introduction
    • 10.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 10.12.5 Hamilton Recent Development
  • 13.13 Macrogen
    • 10.13.1 Macrogen Company Details
    • 10.13.2 Macrogen Business Overview and Its Total Revenue
    • 10.13.3 Macrogen NGS-based RNA-sequencing Introduction
    • 10.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 10.13.5 Macrogen Recent Development
  • 13.14 Zymo Research
    • 10.14.1 Zymo Research Company Details
    • 10.14.2 Zymo Research Business Overview and Its Total Revenue
    • 10.14.3 Zymo Research NGS-based RNA-sequencing Introduction
    • 10.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 10.14.5 Zymo Research Recent Development
  • 13.15 Tecan Genomics
    • 10.15.1 Tecan Genomics Company Details
    • 10.15.2 Tecan Genomics Business Overview and Its Total Revenue
    • 10.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
    • 10.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2015-2020)
    • 10.15.5 Tecan Genomics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global NGS-based RNA-sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the NGS-based RNA-sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Illumina
    Thermo Fischer Scientific
    Oxford Nanopore
    Agilent Technologies
    BGI
    PerkinElmer
    QIAGEN
    Eurofins Scientific
    Roche
    Takara Bio
    GENEWIZ
    Hamilton
    Macrogen
    Zymo Research
    Tecan Genomics

    Market segment by Type, the product can be split into
    Sequencing by Synthesis
    Ion Semiconductor Sequencing
    Single-molecule Real-time Sequencing
    Nanopore Sequencing
    Market segment by Application, split into
    Research & Academia
    Hospitals & Clinics
    Pharmaceutical & Biotechnology Companies
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global NGS-based RNA-sequencing status, future forecast, growth opportunity, key market and key players.
    To present the NGS-based RNA-sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of NGS-based RNA-sequencing are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now